Long term hearing degeneration after platinum-based chemotherapy in childhood

References

• Bertolini P., Lassalle M., Mercier G., Raquin M.A., Izzi G. . 2004. Platinum compound-related ototoxicity in children: Long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol, 26, 649–655.
   Web of Science ®Google Scholar
• Blair J., Peterson M., Myers S.F. 1985. The effects of mild hearing loss on academic performance of young school-age children. Volta Review, 87, 87–93.
   Web of Science ®Google Scholar
• Blakely B.W., Myers S.F. 1993. Patterns of hearing loss resulting from cis-platinum therapy. Otolaryngol Head Neck Surg, 109, 385–391.
   PubMedGoogle Scholar
• Brock P.R., Bellman S.C., Yeomans E.C., Pinkerton C.R., Pritchard J. 1991. Cisplatin ototoxicity in children: A practical grading system. Med Pediatr Oncol, 19, 295–300.
   PubMedGoogle Scholar
• Campbell K. 2003. Ototoxicity: Understanding oxidative mechanisms. J Am Acad Audiol, 14, 121–123.
   PubMedGoogle Scholar
• Campbell K.C., Meech R.P., Rybak L.P., Hughes L.F. 1999. D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res, 138, 13–28.
   PubMed Web of Science ®Google Scholar
• Cardinaal R.M., de Groot J.C., Huizing E.H., Veldman J.E., Smoorenburg G.F. 2000. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res, 144, 135–146.
   PubMed Web of Science ®Google Scholar
• Chen W.C., Jackson A., Budnick A.S., Pfister D.G., Kraus D.H. . 2006. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer, 106, 820–829.
   PubMed Web of Science ®Google Scholar
• de Groot J.C., Hamers F.P., Gispen W.H., Smoorenburg G.F. 1997. Co-administration of the neurotrophic ACTH(4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin. Hear Res, 106, 9–19.
   PubMedGoogle Scholar
• Eriksson-Mangold M., Hallberg L., Erlandsson S. 1990. Hearing loss and experienced handicap. HMS in Swedish: Psychological Department, University of Göteborg, Sweden.
   Google Scholar
• Fausti S.A., Larson V.D., Noffsinger D., Wilson R.H., Phillips D.S. . 1994. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear, 15, 232–239.
   PubMed Web of Science ®Google Scholar
• Helson L., Okonkwo E., Anton L., Cvitkovic E. 1978. cis-Platinum ototoxicity. Clin Toxicol, 13, 469–478.
   PubMed Web of Science ®Google Scholar
• Ilveskoski I., Saarinen U.M., Wiklund T., Perkkio M., Salmi T.T. . 1996. Ototoxicity in children with malignant brain tumors treated with the ‘8 in 1’ chemotherapy protocol. Med Pediatr Oncol, 27, 26–31.
   PubMedGoogle Scholar
• Jerger J. 1970. Clinical experience with impedance audiometry. Arch Otolaryngol, 92, 311–324.
   PubMed Web of Science ®Google Scholar
• Knight K.R., Kraemer D.F, Neuwelt E.A. 2005. Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol, 23, 8588–8596.
   PubMed Web of Science ®Google Scholar
• Kohn S., Fradis M., Podoshin L, Ben David Y., Zidan J. . 1991. Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs. Laryngoscope, 101, 709–716.
   PubMed Web of Science ®Google Scholar
• Li Y., Womer R.B., Silber J.H. 2004. Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur J Cancer, 40, 2445–2451.
   PubMed Web of Science ®Google Scholar
• Liden G., Fant G. 1954. Swedish word material for speech audiometry and articulation tests. Acta Otolaryngol Suppl, 116, 189–204.
   PubMedGoogle Scholar
• Littman T.A., Magruder A., Strother D.R. 1998. Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: Pediatric case study. J Am Acad Audiol, 9, 257–262.
   PubMedGoogle Scholar
• Lonsbury-Martin B.L., Martin G.K. 2001. Evoked otoacoustic emissions as objective screeners for ototoxicity. Seminars in Hearing 22, 377–391.
   Google Scholar
• McHaney V.A., Thibadoux G., Hayes F.A., Green A.A. 1983. Hearing loss in children receiving cisplatin chemotherapy. J Pediatr, 102, 314–317.
   PubMed Web of Science ®Google Scholar
• Meech R.P., Campbell K.C., Hughes L.P., Rybak L.P. 1998. A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear Res, 124, 44–59.
   PubMed Web of Science ®Google Scholar
• Montaguti M., Brandolini C., Ferri G.G., Hatzopoulos S., Prete A. . 2002. Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention. Acta Otorhinolaryngol Ital, 22, 14–18.
   PubMedGoogle Scholar
• Noble W.G. 1979. Test Manual for the Hearing Measurement Scale. Armidale: University of New England.
   Google Scholar
• Noble W.G., Atherley G. 1970. The hearing measurement scale: A questionnaire for the assessment of auditory disability. Journal of Auditory Research, 10, 229–250.
   Google Scholar
• Ress B.D., Sridhar K.S., Balkany T.J., Waxman G.M., Stagner B.B. . 1999. Effects of cis-platinum chemotherapy on otoacoustic emissions: The development of an objective screening protocol. Third place, Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg, 121, 693–701.
   PubMed Web of Science ®Google Scholar
• Rybak L.P. 1981. Cis-platinum associated hearing loss. J Laryngol Otol, 95, 745–747.
   PubMed Web of Science ®Google Scholar
• Schmidt CM, Knief A, Lagosch AK, . 2008. Left-right asymmetry in hearing loss following cisplatin therapy in children - The left ear is slightly but significantly more affected. Ear Hear, 29, 830–837.
   PubMed Web of Science ®Google Scholar
• Schweitzer V.G. 1993. Cisplatin-induced ototoxicity: The effect of pigmentation and inhibitory agents. Laryngoscope, 103, 1–52.
   PubMed Web of Science ®Google Scholar
• Skinner R., Pearson A.D., Amineddine H.A., Mathias D.B, Craft A.W. 1990. Ototoxicity of cisplatinum in children and adolescents. Br J Cancer, 61, 927–931.
   PubMed Web of Science ®Google Scholar
• Tange R.A., Vuzevski V.D. 1984. Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch Otorhinolaryngol, 239, 41–47.
   PubMed Web of Science ®Google Scholar
• Waters G.S., Ahmad M., Katsarkas A., Stanimir G., McKay J. 1991. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: Influence of dosage and schedule of administration. Ear Hear, 12, 91–102.
   PubMed Web of Science ®Google Scholar